Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinicopathological Analysis of Factors Associated With the Development of Adverse Events During Physical Therapy Intervention in Neurocritical Patients in the Intensive Care Unit

NCT07901140 is registered in ClinicalTrials.gov with Hospital H+ Queretaro as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07901140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Clinicopathological Analysis of Factors Associated With the Development of Adverse Events During Physical Therapy Intervention in Neurocritical Patients in the Intensive Care Unit
Lead sponsor
Hospital H+ Queretaro
Phase
Observational
Overall status
Active, not recruiting
Start date
September 23, 2026
Completion date
October 31, 2026
Enrollment
47 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

Arms

As registered; 2 arms.

  • Adverse Event Group Physical Therapy Intervention

    Adult neurocritical ICU patients who presented at least one adverse event (e.g., hypotension, hypertension, tachycardia, bradycardia, oxygen desaturation, increased ICP, decreased CPP, acute neurological deterioration) during the physical therapy intervention.

  • No Adverse Event Group Physical Therapy Intervention

    Adult neurocritical ICU patients who underwent physical therapy intervention without experiencing any adverse events during the session.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Incidence of Adverse Events During Physical Therapy During the physical therapy session (from initiation up to immediate post-session evaluation, up to 1 hour per session).

    Presence or absence of any adverse event (binary variable: Yes/No) occurring during or immediately following a physical therapy session in adult neurocritical ICU patients. Adverse events include: hypotension (drop in SBP \> 20 mmHg), hypertension, tachycardia, bradycardia, oxygen desaturation, acute neurological deterioration, increase in intracranial pressure (ICP), or decrease in cerebral perfusion pressure (CPP) requiring therapy session suspension.

Lead sponsor's other trials

Hospital H+ Queretaro, most recent start first.

Similar trials

Same condition (Orthostatic Intolerance) and phase, most recent start first.